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previously been shown to be important in regulating lipoprotein
metabolism. Using a ﬂoxed allele ofmesd, we are examining the effects
of tissue-speciﬁc loss of MESD on plasma lipoprotein levels and arterial
plaque formation. This work was supported by GM5396407 to BCH.
doi:10.1016/j.ydbio.2008.05.334
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Spinal muscular atrophy (SMA) is an autosomal recessive disorder
characterized by a loss of α-motoneurons in the spinal cord. SMA is
causedby low levels of theubiquitouslyexpressed SurvivalMotorNeuron
(Smn) protein. Inprevious studies,we have shown thatmorpholino (MO)
knockdown of smn in zebraﬁsh embryos results in motor axon-speciﬁc
outgrowthdefects. To obtain a genetic zebraﬁshmodel of this disease,we
have identiﬁed 3 smn mutations by TILLING. smn−/− zebraﬁsh have high
maternal Smnprotein; at 11dpf, however, protein levels are undetectable
and the larvae die at 11–12 dpf. Synapse analysis reveals NMJ changes
consistent with denervation inmutants (andmorphants). To address the
function of Smn, we knocked down Gemin2, a Smn-binding protein
involved in snRNP assembly. gemin2 MO knockdown in the entire
embryo showed overall abnormal development. However, when we
knocked downGemin2 speciﬁcally inmotoneurons (either by iontophor-
esis or blastula transplantation), their axons developed normally. These
data show that reduction of Gemin2, unlike Smn, does not directly cause
motor axon outgrowth defects, which is consistent with an snRNP-
independent role for Smn in motoneurons. Funding sources include:
Families of SMA grants MCW2006 (MLM) and BOO2008 (KLB); NIH
grants RO1NS050414 (CEB) and P30-NS045758.
doi:10.1016/j.ydbio.2008.05.335
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The presynaptic protein, α-synuclein, appears to play a key role in
the pathogenesis of Parkinson's disease but the normal cellular
functions of synuclein proteins remain a mystery. Understanding the
role of α-synuclein during normal development will provide insight
into its later role in pathophysiology. The zebraﬁsh is a powerful
vertebrate model system for studying many important developmental
processes. We hypothesized that the simpler nervous system of zeb-
raﬁsh might allow us to readily explore the functions of synucleins.
We cloned three novel synuclein genes from zebraﬁsh and have found
that they are expressed strongly in the nervous system. We are
performing loss-of-function experiments using morpholino-modiﬁed
antisense oligonucleotides to determine the effect of losing one, two,
or three synucleins. The phenotypes we observe will suggest potential
cellular functions for these zebraﬁsh synucleins and will provide
hypotheses to test in higher systems, such as mouse and rat.
doi:10.1016/j.ydbio.2008.05.336
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Type III 3-methylglutaconic aciduria (MGA-III) is a rare disorderwith
neuro-opthamalgicmanifestations and increased urinary excretion of 3-
methylglutaric acid (3MGA). Two familial mutations have been found in
the OPA3 gene associated with MGA-III. We found that the zebraﬁsh
Opa3 orthologue is expressed ubiquitously during embryogenesis and is
enriched in the brain from the pharyngula stage until at least 120 hpf.
Antisense-based depletion of zebraﬁsh Opa3 causes the signature
increase in 3MGA, but also a more severe eye defect than seen in
MGA-III patients. To explore whether Opa3 acts in the leucine catabolic
pathway,wedelivered exogenous leucine toOpa3-deﬁcientembryos.As
a comparison, leucine delivery to an MGA-I model deﬁcient for the
leucine catabolic pathway enzyme 3-methylglutaconyl-CoA hydratase
causes nomorphological defects, but leads to a sharp increase in leucine,
and 3MGA. In contrast, leucine-treated Opa3-deﬁcient embryos display
severe brain dysmorphology but no accumulation of leucine or 3MGA.
We also examined the effects on Opa3-deﬁcient embryos of mevalo-
nate-depletion via simvastatin treatment, and found that simvastatin
causes additional braindefects inOpa3-deﬁcient embryos.Wehave thus
uncovered two classes of metabolic sensitivity that are speciﬁc to the
brain of our zebraﬁsh MGA-III model, indicating that zebraﬁsh Opa3
interacts with both the leucine and mevalonate pathways.
doi:10.1016/j.ydbio.2008.05.337
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The larval zebraﬁsh (Danio rerio) is an ideal model of vertebrate
intestinal physiology because of its rapid development and optical
clarity. This systemallows for thedirect observationofﬂuorescent lipids,
fusion proteins, and reporter gene constructs within the developing
animal. Data fromavarietyof vertebrates indicates thatdietary lipids are
initially absorbed by intestinal enterocytes. Since energy homeostasis
relies on dietary lipids, how enterocytes process lipids profoundly
impacts whole animal lipidmetabolism.While several studies implicate
various subcellular compartments and proteins in the absorptive
process, many questions remain. The highly dynamic nature of the
absorptive process and the subcellular structures are difﬁcult to image in
mammals. An accurate model of intestinal physiology will reﬂect the
combined action of both organelles as well as many cell types. We have
begun the characterization of lipid uptake by zebraﬁsh intestinal
enterocytes. The ability to perform real-time in vivo lipid absorption
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studieswill be essential for developing anunderstanding of dietary lipid
processing and facilitate the identiﬁcation of new therapeutic targets.
We have developed an assay to observe lipid absorption at the single
enterocyte level using lipophilic dyes in zebraﬁsh larvae that express
ﬂuorescent fusion proteins. When larvae are fed a high fat diet,
enterocytes accumulate lipid droplets that can be visualized in real-
time in live animals. The intracellular fate of these newly absorbed lipids
was examined by co-localization of well-characterized ﬂuorescent
fusion proteins important for endocytosis and trafﬁcking of lipids.
doi:10.1016/j.ydbio.2008.05.338
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Valproic acid (VPA) is a short-chain fatty acid that is widely used
to treat epilepsy and bipolar disorder. However, VPA treatment during
pregnancy is associated with neural tube defects, cardiac malforma-
tions, craniofacial abnormalities, and limb defects. The mechanism by
which these developmental defects occur is poorly understood. Our
lab has shown that VPA directly inhibits histone deacetylases
(HDACs). We are using Xenopus laevis as a model system to study
the consequences of VPA mediated HDAC inhibition in early
development. Administering a therapeutically relevant dose of VPA
(1–2 mM) to gastrulating Xenopus embryos causes heart looping
abnormalities, pericardial edema, and a signiﬁcant reduction in
circulating red blood cells. However, overall development appears
essentially normal, and markers of dorsal and lateral mesoderm are
grossly normal, suggesting a relatively restricted effect of VPA under
this treatment regimen. We have found that VPA signiﬁcantly reduces
expression of the hematopoietic marker Xenopus acute myeloid
leukemia (Xaml/runx1) speciﬁcally in the ventral blood islands. The
reduction of Xaml expression can be recapitulated by another HDAC
inhibitor, Trichostatin A (TSA), but not by valpromide (VPM), a
structural analog of VPA that does not inhibit HDACs, suggesting that
the effects of VPA are mediated through HDAC inhibition. Our future
studies will focus on understanding the mechanism by which VPA
and HDAC inhibitions disrupt erythropoiesis during early
development.
doi:10.1016/j.ydbio.2008.05.339
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